Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Reality trial team"'
Autor:
Cissy Kityo, Alexander J Szubert, Abraham Siika, Robert Heyderman, Mutsa Bwakura-Dangarembizi, Abbas Lugemwa, Shalton Mwaringa, Anna Griffiths, Immaculate Nkanya, Sheila Kabahenda, Simon Wachira, Godfrey Musoro, Chatu Rajapakse, Timothy Etyang, James Abach, Moira J Spyer, Priscilla Wavamunno, Linda Nyondo-Mipando, Ennie Chidziva, Kusum Nathoo, Nigel Klein, James Hakim, Diana M Gibb, A Sarah Walker, Sarah L Pett, REALITY trial team
Publikováno v:
PLoS Medicine, Vol 15, Iss 12, p e1002706 (2018)
BackgroundIn sub-Saharan Africa, individuals infected with HIV who are severely immunocompromised have high mortality (about 10%) shortly after starting antiretroviral therapy (ART). This group also has the greatest risk of morbidity and mortality as
Externí odkaz:
https://doaj.org/article/58c232363de740f49929ba0af610abb9
Autor:
Reduction of EArly mortaLITY in HIV-infected adults and children starting antiretroviral therapy (REALITY) Trial Team, Post, Frank A., Szubert, Alexander J., Prendergast, Andrew J., Johnston, Victoria, Lyall, Hermione, Fitzgerald, Felicity, Musiime, Victor, Musoro, Godfrey, Chepkorir, Priscilla, Agutu, Clara, Mallewa, Jane, Rajapakse, Chathurika, Wilkes, Helen, Hakim, James, Mugyenyi, Peter, Walker, A. Sarah, Gibb, Diana M., Pett, Sarah L.
Publikováno v:
Clinical Infectious Diseases, 2018 Apr 01. 66, S132-S139.
Externí odkaz:
https://www.jstor.org/stable/26525981
Autor:
REALITY Trial Team, Siika, Abraham, McCabe, Leanne, Bwakura-Dangarembizi, Mutsa, Kityo, Cissy, Mallewa, Jane, Berkley, Jay, Maitland, Kath, Griffiths, Anna, Baleeta, Keith, Mudzingwa, Shepherd, Abach, James, Nathoo, Kusum, Thomason, Margaret J., Prendergast, Andrew J., Walker, Ann Sarah, Gibb, Diana M.
Publikováno v:
Clinical Infectious Diseases, 2018 Apr 01. 66, S140-S146.
Externí odkaz:
https://www.jstor.org/stable/26525982
Autor:
K Magut Cornelius, Moira J. Spyer, Robert S. Heyderman, James Hakim, Laura A Benjamin, Cissy Kityo, Amin S. Hassan, Ruth Nhema, Juliet Kitabalwa, Godfrey Musoro, Reality trial team, George Selemani, Chrispus Katemba, Diana M. Gibb, Sarah Pett, Grace Najjuka, Lewis J. Haddow, Sithembile Bilima, AS Walker, J A Berkley, Ibrahim I. Daud, Salome Kandie
Publikováno v:
AIDS
Objectives: To assess baseline prevalence of cryptococcal antigen (CrAg) positivity; and its contribution to reductions in all-cause mortality, deaths from cryptococcus and unknown causes, and new cryptococcal disease in the REALITY trial. Design: Re
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mallewa, Jane, Szubert, Alexander J, Mugyenyi, Peter, Chidziva, Ennie, Thomason, Margaret J, Chepkorir, Priscilla, Abongomera, George, Baleeta, Keith, Etyang, Anthony, Warambwa, Colin, Melly, Betty, Mudzingwa, Shepherd, Kelly, Christine, Agutu, Clara, Wilkes, Helen, Nkomani, Sanele, Musiime, Victor, Lugemwa, Abbas, Pett, Sarah L, Bwakura-Dangarembizi, Mutsa, Prendergast, Andrew J, Gibb, Diana M, Walker, A Sarah, Berkley, James A., REALITY Trial Team, O'Hare, Bernadette
Publikováno v:
The Lancet. HIV
E240
E231
E240
E231
Funding: Joint Global Health Trials Scheme (UK Medical Research Council, UK Department for International Development, and Wellcome Trust). BACKGROUND: In sub-Saharan Africa, severely immunocompromised HIV-infected individuals have a high risk of mort
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Reality Trial Team, Sarah Bernays, Janet Seeley, Rachel Kawuma, Frances M. Cowan, Zivai Mupambireyi
Publikováno v:
African journal of AIDS research : AJAR. 17(3)
We examined the logic that individuals use to account for delaying HIV testing and/or initiating HIV treatment. Our qualitative study, situated within the REALITY trial (Reduction of EArly mortaLITY in HIV infected adults and children starting antire
Autor:
A. Sarah Walker, Godfrey Musoro, Felicity Fitzgerald, Helen Wilkes, Sarah Pett, Andrew J. Prendergast, Victor Musiime, Frank A. Post, Diana M. Gibb, Peter Mugyenyi, Clara A. Agutu, Hermione Lyall, Priscilla Chepkorir, Alexander J. Szubert, Chathurika Rajapakse, James Hakim, Jane Mallewa, Victoria Johnston, children starting antiretroviral therapy (Reality) Trial Team
Publikováno v:
S139
S132
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
S132
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background: In sub-Saharan Africa, 20%-25% of people starting ART have severe immunosuppression; ~10% die within three months. In the recently-reported REALITY randomized trial, a broad enhanced anti-infection prophylaxis bundle reduced all-cause mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a009f4643f4f62bfa41c7cd306a1d433
https://researchonline.lshtm.ac.uk/id/eprint/4646934/1/Causes-and-Timing-of-Mortality-and-Morbidity-Among-Late-Presenters-Starting-Antiretroviral-Therapy-in-the-REALITY-Trial.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4646934/1/Causes-and-Timing-of-Mortality-and-Morbidity-Among-Late-Presenters-Starting-Antiretroviral-Therapy-in-the-REALITY-Trial.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.